Chemoradiotherapy with gemcitabine and continuous 5-FU in patients with primary inoperable pancreatic cancer

Journal of the Pancreas

Volumn 7, Issue 4, 2006, Pages 349-360

  Wilkowski, Ralf ^a   Thoma, Martin ^a   Bruns, Christiane ^a   Wagner, Andreas ^a   Heinemann, Volker ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Combined modality therapy; Drug therapy; Fluorouracil; Gemcitabine; Pancreatic neoplasms; Radiation oncology; Radiotherapy

Indexed keywords

CISPLATIN; FLUOROURACIL; GEMCITABINE; METOCLOPRAMIDE; ONDANSETRON; RADIOSENSITIZING AGENT; STEROID;

ABSENCE OF SIDE EFFECTS; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CHOLANGITIS; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; CYTOTOXICITY; DISEASE COURSE; DOSE RESPONSE; DRUG EFFICACY; DRUG FATALITY; DRUG INFUSION; DRUG POTENTIATION; DRUG SAFETY; EROSIVE GASTRITIS; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HISTOPATHOLOGY; HUMAN; INOPERABLE CANCER; LAPAROTOMY; LEUKOPENIA; LIVER INJURY; LUNG EMBOLISM; MALE; METASTASIS; NAUSEA AND VOMITING; OVERALL SURVIVAL; PANCREAS CARCINOMA; PANCREAS RESECTION; PREOPERATIVE CARE; PROGNOSIS; RADIATION DOSE; RADIATION ENTEROPATHY; REOPERATION; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; DISEASE PROGRESSION; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PANCREATIC NEOPLASMS; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 33746129951     PISSN: 15908577     EISSN: 15908577     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Kelly DM, Benjamin IS. Pancreatic carcinoma. Ann Oncol 1995; 6:19-28. [PMID 7536026]
2. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin 1996; 46:5-27. [PMID 8548526]
3. Moertel CG, Frytak S, Hahn RG, O'Connell MJ, Reitemeier RJ, Rubin J, et al. Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group. Cancer 1981; 48:1705-10. [PMID 7284971]
4. Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. Gastrointestinal Tumor Study Group. J Natl Cancer Inst 1988; 80:751-5. [PMID 2898536]
5. Brunner TB, Grabenbauer GG, Baum U, Hohenberger W, Sauer R. Adjuvant and neoadjuvant radiochemotherapy in ductal pancreatic carcinoma. Strahlenther Onkol 2000; 176:265-73. [PMID 10897253]
6. Jessup JM, Steele G Jr, Mayer RJ, Posner M, Busse P, Cady B, et al. Neoadjuvant therapy for unresectable pancreatic adenocarcinoma. Arch Surg 1993; 128:559-64. [PMID 8098206]
7. Pilepich MV, Miller HH. Preoperative irradiation in carcinoma of the pancreas. Cancer 1980; 46:1945-9. [PMID 7427900]
8. Burris HA 3rd, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, et al. Improvements in survival and clinical benefit with gemcitabine as firstline therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 1997; 15:2403-13. [PMID 9196156]
9. Carmichael J, Fink U, Russell RC, Spittle MF, Harris AL, Spiessi G, Blatter J. Phase II study of gemcitabine in patients with advanced pancreatic cancer. Br J Cancer 1996; 73:101-5. [PMID 8554969]
10. Casper ES, Green MR, Kelsen DP, Heelan RT, Brown TD, Flombaum CD, et al. Phase II trial of gemcitabine (2,2′-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas. Invest New Drugs 1994; 12:29-34. [PMID 7960602]
11. Lawrence TS, Chang EY, Hahn TM, Hertel LW, Shewach DS. Radiosensitization of pancreatic cancer cells by 2′,2′-difluoro-2′-deoxycytidine. Int J Radiat Oncol Biol Phys 1996; 34:867-72. [PMlD 8598364]
12. Mose S, Karapetian M, Juling-Pohlit L, Taborski B, Ramm U, Damrau M, et al. The intensification of the radiotherapeutic effect on HeLa cells by gemcitabine. Strahlenther Onkol 1999; 175:78-83. [PMID 10065143]
13. Rothenberg ML, Moore MJ, Cripps MC, Andersen JS, Portenoy RK, Burris HA 3rd, et al. A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer. Ann Oncol 1996; 7:347-53. [PMID 8805925]
14. Blackstock AW, Bernard SA, Richards F, Eagle KS, Case LD, Poole ME, et al. Phase I trial of twiceweekly gemcitabine and concurrent radiation in patients with advanced pancreatic cancer. J Clin Oncol 1999; 17:2208-12. [PMID 10561277]
15. Epelbaum R. Rosenblatt E, Nasrallah S, Muler E, Yardeni T, Faraggi D, Kopelman D, Mizrahi S, Kuten A. A phase II study of gemcitabine (Gem) combined with radiation therapy (RT) in patients with localized, unresectable pancreatic cancer. Proc Am Soc Clin Oncol 2000; 19:A1029 (Abstr).
16. Hoffman JP, McGinn CJ, Szarka C, Morphis J, Cooper HS, Wilkes J, Nicol S. A phase I study of preoperative gemcitabine (GEM) with radiation therapy (RT) followed by postoperative GEM for patients with localized, resectable pancreatic adenocarcinoma (PaC). Proc Am Soc Clin Oncol 1998; 17:A 1090 (Abstr).
17. Kudrimoti M, Regine W, John W, Hanna N, Mohiuddin M. Concurrent infusional gemcitabine and radiation in the treatment of advanced unresectable GI malignancy: a phase I/II study. Proc Am Soc Clin Oncol 1999; 18:A928 (Abstr).
18. Maurer U, Stegmeier P, Bolte R. Gemcitabine (G) in combination radiation therapy (RT) in stage III-IV pancreatic cancer: First results of a current phase I study. Eur J Cancer 1999; 35 (Suppl. 4):A544 (Abstr).
19. McGinn CJ, Smith DC, Szarka CE, Pinover WH, Loehrer PJ, Morphis JG, et al. A phase I study of gemcitabine (GEM) in combination with radiation therapy (RT) in patients with localized, unresectable pancreatic cancer. Proc Am Soc Clin Oncol 1998; 17:A1014 (Abstr).
20. Reyes-Vidal J, Rodriguez P, Reyes J, Buckel E, Veit O, Orlandi L, Baeza R. Chemoradiation therapy with gemcitabine (Gem) in advanced pancreatic cancer. Proc Am Soc Clin Oncol 2000; 19:A 1183 (Abstr).
21. de Lange SM, van Groeningen CJ, Meijer OW, Cuesta MA, Langendijk JA, van Riel JM, et al. Gemcitabine-radiotherapy in patients with locally advanced pancreatic cancer. Eur J Cancer 2002; 38:1212-7. [PMlD 12044508]
22. Ikeda M, Okada S, Tokuuye K, Ueno H, Okusaka T. A phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with locally advanced pancreatic cancer. Br J Cancer 2002; 86:1551-4. [PMID 12085203]
23. Wilkowski R, Thoma M, Schauer R, Wagner A, Heinemann V. Effect of chemoradiotherapy with gemcitabine and eisplatin on locoregional control in patients with primary inoperable pancreatic cancer. World J Surg 2004; 28:1011-8. [PMJD 15573257]
24. Yavuz A, Aydin F, Yavuz M, Ilis E, Yaris N. A phase I trial of radiation therapy (RT) plus concurrent fixed dose amifostine (Ami) with escalating doses of twice-weekly gemcitabine in advanced pancreatic cancer. Proc Am Soc Clin Oncol 2000; 19:A1105 (Abstr).
25. Brunner TB, Grabenbauer GG, Klein P, Baum U, Papadopoulos T, Bautz W, et al. Phase I trial of strictly time-scheduled gemcitabine and cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 2003; 55:144-153. [PMID 12504047]
26. Wilkowski R, Stoffregen C, Rau H-G, Heiss MM, Thoma M, Dühmke E, Langer F, Heinemann V. Chemoradiation with Gemcitabine (G) in Primary Inoperable Pancreatic Cancer. Proc Am Soc Clin Oncol 2001; 20:A2317 (Abstr).
27. Crane CH, Janjan NA, Evans DB, Wolff RA, Ballo MT, Milas L, et al. Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer. Int J Pancreatol 2001; 29:9-18. [PMID 11560155]
28. Talamonti MS, Catalano PJ, Vaughn DJ, Whittington R, Beauchamp RD, Berlin J, Benson AB 3rd. Eastern Cooperative Oncology Group Phase I trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapy in patients with locally advanced pancreas cancer: a regimen with unexpected early toxicity. J Clin Oncol 2000; 18:3384-9. [PMID 11013279]
29. McGinn CJ, Zalupski MM, Shureiqi I, Robertson JM, Eckhauser FE, Smith DC, et al. Phase I trial of radiation dose escalation with concurrent weekly fulldose gemcitabine in patients with advanced pancreatic cancer. J Clin Oncol 2001; 19:4202-8. [PMID 11709563]
30. Bajetta E, Di Bartolomeo M, Stani SC, Artale S, Ricci SB, Bozzetti F, et al. Chemoradiotherapy as preoperative treatment in locally advanced unresectable pancreatic cancer patients: results of a feasibility study. Int J Radiat Oncol Biol Phys 1999; 45:285-9. [PMlD 10487547]
31. Osti MF, Costa AM, Bianciardi F, De Nicolo M, Donato V, Silecchia G, Enrici, RM. Concomitant radiotherapy with protracted 5-fluorouracil infusion in locally advanced carcinoma of the pancreas: a phase II study. Tumori 2001; 87:398-401. [PMID 11989594]
32. Mawdsley S, Hall M, Glynne-Jones R. Locally advanced pancreatic cancer treated with radiation and 5-fluorouracil. Clin Oncol (R Coll Radiol) 2002; 14:308-12. [PMID 12206644]
33. Li CP, Chao Y, Chi KH, Chan WK, Teng HC, Lee RC, et al. Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: gemcitabine versus 5-fluorouracil, a randomized controlled study. Int J Radiat Oncol Biol Phys 2003; 57:98-104. [PMID 12909221]